Filing Flows › cbdMD (YCBD) › Q3 FY26
cbdMD (YCBD) Q3 FY26 earnings results (third quarter fiscal 2026)
10-Q filed Aug 13, 2026
cbdMD (YCBD) reported revenue of $5.6M for the third quarter fiscal 2026 (Q3 FY26), +21% from a year earlier and -2% from the quarter before. Operating margin was -20.4%, net loss $1.1M (20.3% of revenue).
cbdMD, Q3 FY26: revenue $5.6M (+21% year over year), operating margin -20.4%, net loss $1.1M, operating cash flow −$442K. The chart follows the revenue to costs, profit and cash.
| Q3 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.6M | -2% | +21% |
| Operating profit | −$1.1M | — | — |
| Net earnings | −$1.1M | — | — |
| Operating cash flow | −$442K | — | — |
What changed
Revenue was $5.6M in Q3 FY26, up 21% year over year and down 2% from the previous quarter.
Gross margin was 54.7%, down 6.8 points from Q3 FY25. Operating costs exceeded revenue by $1.1M, an operating margin of -20.4%. Operating expenses grew 12% against revenue growth of 21%. The quarter ended with a net loss of $1.1M, wider than the previous quarter's $798K loss.
Operating cash flow was −$442K. Non-cash charges added back $259K of depreciation and amortization. Working capital and other items added $426K. Capital expenditures of $18K exceeded it, leaving free cash flow of −$460K.
Questions
What was cbdMD's revenue in the third quarter fiscal 2026?
cbdMD (YCBD) reported revenue of $5.6M for the third quarter fiscal 2026 (Q3 FY26), +21% from a year earlier and -2% from the quarter before.
Was cbdMD profitable in the third quarter fiscal 2026?
Operating loss was $1.1M (-20.4% of revenue) and net loss $1.1M.
Source: cbdMD 10-Q on SEC EDGAR.